Semi-Annual Statement Of Changes In Equity

K Pharma,Inc. - Filing #7344418

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Semi-annual statement of changes in equity
Statement of changes in equity
Net assets
974,700,000 JPY
854,087,000 JPY
3,104,768,000 JPY
-752,656,000 JPY
3,104,768,000 JPY
2,028,637,000 JPY
3,003,337,000 JPY
-752,656,000 JPY
-1,012,986,000 JPY
1,336,263,000 JPY
1,274,550,000 JPY
2,249,250,000 JPY
1,336,263,000 JPY
100,000,000 JPY
-1,012,986,000 JPY
974,700,000 JPY
-620,559,000 JPY
178,891,000 JPY
100,000,000 JPY
-620,559,000 JPY
199,800,000 JPY
499,650,000 JPY
699,450,000 JPY
178,891,000 JPY
Changes during period
Issuance of new shares
1,508,174,000 JPY
754,087,000 JPY
1,508,174,000 JPY
754,087,000 JPY
754,087,000 JPY
774,900,000 JPY
774,900,000 JPY
1,549,800,000 JPY
774,900,000 JPY
1,549,800,000 JPY
Profit (loss)
260,330,000 JPY
260,330,000 JPY
260,330,000 JPY
260,330,000 JPY
-392,427,000 JPY
-392,427,000 JPY
-392,427,000 JPY
-392,427,000 JPY
Total changes during period
1,768,504,000 JPY
JPY
754,087,000 JPY
260,330,000 JPY
1,768,504,000 JPY
754,087,000 JPY
260,330,000 JPY
754,087,000 JPY
774,900,000 JPY
-392,427,000 JPY
JPY
-392,427,000 JPY
774,900,000 JPY
1,157,372,000 JPY
1,549,800,000 JPY
1,157,372,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.